MedTrace Logo

Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis

NCT00565123 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2007-11-29

No results posted yet for this study

Summary

The aim of the study is to evaluate the clinical and microbiological efficacies of three times daily administration of levofloxacin 0,5% eye drops as compared to the more frequent dosing (up to 8 times a day during the first 2 days and up to 4 times a day during the next 3 days) in patients with bacterial conjunctivitis.

Conditions

  • Bacterial Conjunctivitis

Interventions

DRUG

0.5% levofloxacin eye drops

0.5% levofloxacin eye drops three times daily to each eye for 5 days

DRUG

0.5% levofloxacin eye drops

0.5% levofloxacin eye drops 2 hours on days 1 and 2, and then every 4 hours on days 3-5 (up to 4 times per day)

Sponsors & Collaborators

  • Katedra I Klinika Okulistyki II Wydz. Lek. AM w Warszawie,

    collaborator UNKNOWN

  • University Hospital No 1 Wroclaw

    collaborator OTHER

  • MedSource Polska

    collaborator INDUSTRY

  • Laser Microsurgery Centre, Poland

    lead OTHER

Principal Investigators

  • Jerzy Szaflik, MD,Ph.D. · Laser Microsurgery Centre; Department of Ophthalmology, Medical University of Warsaw

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Completion
2006-01-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00565123 on ClinicalTrials.gov